Differential expression of transforming growth factors-β1, -β2 and -β3 in human colon carcinoma

European Journal of Cancer

Volumn 37, Issue 2, 2001, Pages 224-233

  Bellone, G ^a   Carbone, A ^a   Tibaudi, D ^a   Mauri, F ^b   Ferrero, I ^a   Smirne, C ^a   Suman, F ^a   Rivetti, C ^a   Migliaretti, G ^c   Camandona, M ^a   Palestro, G ^a   Emanuelli, G ^a   Rodeck, U ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b Division of Neurology   (Italy)

^c Reference Center for Cancer Epidemiology and Prevention in Piedmont (CPO Piemonte)   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Colon carcinoma; Transforming growth factor ; Tumour progression

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KNOCKOUT MOUSE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 0035126167     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00391-9     Document Type: Article

References (32)

1. TGF-beta signal transduction
2. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
3. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
4. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
5. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells
6. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells
7. Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability
8. Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer
9. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer
10. A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability
11. Analyses of the APC and TGF-beta type II receptor genes, and microsatellite instability in mucosal colorectal carcinomas
12. Down-regulation of TGF-beta receptors in human colorectal cancer: Implications for cancer development
13. Mutations in the SMAD4/DPC4 gene in juvenile polyposis
14. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer
15. TGF-beta expression in the human colon: Differential immunostaining along crypt epithelium
16. High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer
17. Colon carcinoma cell lines stimulate monocytes and lamina propria mononuclear cells to produce IL-10
18. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes
19. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients
20. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue
21. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1
22. Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia
23. TGF-beta1 in colonic neoplasia: A genetic molecular and immunohistochemical study
24. Detection of serum cytokine levels in experimental cancer cachexia of colon 26 adenocarcinoma-bearing mice
25. Elevated serum levels of transforming growth factor-beta 1 in patients with colorectal carcinoma: Its association with tumor progression and its significant decrease after curative surgical resection
26. High levels of transforming growth factor beta 1 in patients with colorectal cancer: Association with disease progression
27. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
28. Transforming growth factor-beta 3 is required for secondary palate fusion
29. Transforming growth factor beta 1 expression in human colorectal tumours: An independent prognostic marker in a subgroup of poor prognosis patients
30. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis
31. Potentiation of metastatic capacity by transforming growth factor-beta 1 gene transfection
32. Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: Validity of neutralizing antibodies to block tumor growth